The group is extremely multidisciplinary and currently consists of around 30 postdoctoral fellows and PhD students. The group is focussed on both high quality fundamental science and translation for human health. Research in regenerative medicine within the group includes the directed differentiation of stem cells, the design of novel bioactive scaffolds and new approaches towards tissue regeneration. We have developed novel approaches to tissue engineering that are likely to prove very powerful in the engineering of large quantities of human mature bone for autologous transplantation as well as other vital organs such as liver and pancreas, which have proven elusive with other approaches. This has led to moves to commercialise the technology (Prof Stevens is the co-founder of spin-out companies) and set-up a clinical trial for bone regeneration in humans. In the field of nanotechnology the group has current research efforts in exploiting specific biomolecular recognition and self-assembly mechanisms to create new dynamic nano-materials, biosensors and drug delivery systems. Recent efforts by the Stevens group in peptide-functionalised nanoparticles for enzyme biosensing have enabled the most sensitive facile enzyme detection to date and have a host of applications across diseases ranging from cancer to global health applications.
For up to date PICTURES and BACKGROUNDS and listing of GROUP MEMBERS and overview of our research see our group website.The group works closely with the London Centre for Nanotechnology.
***Several PhD and postdoctoral positions in Tissue Engineering and Nanomaterials/Bio-Nanotechnology available - please see our group website for vacancies.***